Vaxcyte, Inc.
$55.64
$2.85(-4.87%)
Vaxcyte, Inc.
PCVX
$55.64
$2.85(-4.87%)
Vaxcyte, Inc.
PCVX
NASDAQ
$55.64
$2.85(-4.87%)
Chart
Upcoming Earnings
Next report date
May 6, 2026
Report period
Q2 2026
EPS Estimate
$-1.74
Revenue Estimate
$12.50M
Key stats
52-Week Range$55.64
$28.09
$65.00
Market capitalization
$8.03BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-10.11Basic EPS (TTM)
$-5.63Net income (TTM)
$-766.63MRevenue (TTM)
$0.00Avg. volume
1.24MBeta (1Y)
1.30Employees
414Market capitalization
$8.03BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-10.11Basic EPS (TTM)
$-5.63Net income (TTM)
$-766.63MRevenue (TTM)
$0.00Avg. volume
1.24MBeta (1Y)
1.30Employees
414Screener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Vaxcyte, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Grant E. Pickering
Website
vaxcyte.comHeadquarters
825 Industrial Road, San Carlos, CA, 94070
IPO Date
2020-06-12
Identifiers
ISIN
US92243G1085Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial...
Related Stocks
$74.93
1D:
-1.9%
1Y:
436.0%
US04280A1007Healthcare
Mkt Cap
$10.49B
P/E Ratio TTM
51.8
Revenue TTM
$1.09B
Beta
1.27
Earnings TTM
$202.27M
Dividend Yield TTM
0.00%
$284.57
1D:
-0.8%
1Y:
75.3%
US5011471027Healthcare
Mkt Cap
$8.38B
P/E Ratio TTM
37.6
Revenue TTM
$389.13M
Beta
0.54
Earnings TTM
$204.83M
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate